Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,203,076
-
Share change
-
-114,999
-
Total reported value
-
$3,603,918,170
-
Put/Call ratio
-
53%
-
Price per share
-
$102.38
-
Number of holders
-
192
-
Value change
-
-$45,507,670
-
Number of buys
-
107
-
Number of sells
-
100
Institutional Holders of SPARK THERAPEUTICS INC - COM (ONCE) as of Q2 2019
As of 30 Jun 2019,
SPARK THERAPEUTICS INC - COM (ONCE) was held by
192 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,203,076 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Magnetar Financial LLC, Casdin Capital, LLC, ALPINE ASSOCIATES MANAGEMENT INC., Pentwater Capital Management LP, FARALLON CAPITAL MANAGEMENT LLC, PAULSON & CO. INC., and BAKER BROS. ADVISORS LP.
This page lists
192
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.